Global Radiopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Radiopharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Radiopharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Radiopharmaceutical segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radiopharmaceutical market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Radiopharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Radiopharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Radiopharmaceutical segment by Company
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radiopharmaceutical market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Radiopharmaceutical Market Size, 2019 VS 2023 VS 2030
1.3 Global Radiopharmaceutical Market Size Estimates and Forecasts (2019-2030)
1.4 Global Radiopharmaceutical Sales Estimates and Forecasts (2019-2030)
1.5 Global Radiopharmaceutical Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL RADIOPHARMACEUTICAL MARKET DYNAMICS
2.1 Radiopharmaceutical Industry Trends
2.2 Radiopharmaceutical Industry Drivers
2.3 Radiopharmaceutical Industry Opportunities and Challenges
2.4 Radiopharmaceutical Industry Restraints
3 RADIOPHARMACEUTICAL MARKET BY MANUFACTURERS
3.1 Global Radiopharmaceutical Revenue by Manufacturers (2019-2024)
3.2 Global Radiopharmaceutical Sales by Manufacturers (2019-2024)
3.3 Global Radiopharmaceutical Average Sales Price by Manufacturers (2019-2024)
3.4 Global Radiopharmaceutical Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Radiopharmaceutical Manufacturers, Product Type & Application
3.7 Global Radiopharmaceutical Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Radiopharmaceutical Market CR5 and HHI
3.8.2 Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2023
3.8.3 2023 Radiopharmaceutical Tier 1, Tier 2, and Tier
4 RADIOPHARMACEUTICAL MARKET BY TYPE
4.1 Radiopharmaceutical Type Introduction
4.1.1 Actinium-225
4.1.2 Lutetium-177
4.1.3 Radium-223
4.1.4 Holmium-166
4.1.5 Other
4.2 Global Radiopharmaceutical Sales by Type
4.2.1 Global Radiopharmaceutical Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Radiopharmaceutical Sales by Type (2019-2030)
4.2.3 Global Radiopharmaceutical Sales Market Share by Type (2019-2030)
4.3 Global Radiopharmaceutical Revenue by Type
4.3.1 Global Radiopharmaceutical Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Radiopharmaceutical Revenue by Type (2019-2030)
4.3.3 Global Radiopharmaceutical Revenue Market Share by Type (2019-2030)
5 RADIOPHARMACEUTICAL MARKET BY APPLICATION
5.1 Radiopharmaceutical Application Introduction
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Other
5.2 Global Radiopharmaceutical Sales by Application
5.2.1 Global Radiopharmaceutical Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Radiopharmaceutical Sales by Application (2019-2030)
5.2.3 Global Radiopharmaceutical Sales Market Share by Application (2019-2030)
5.3 Global Radiopharmaceutical Revenue by Application
5.3.1 Global Radiopharmaceutical Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Radiopharmaceutical Revenue by Application (2019-2030)
5.3.3 Global Radiopharmaceutical Revenue Market Share by Application (2019-2030)
6 GLOBAL RADIOPHARMACEUTICAL SALES BY REGION
6.1 Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Radiopharmaceutical Sales by Region (2019-2030)
6.2.1 Global Radiopharmaceutical Sales by Region (2019-2024)
6.2.2 Global Radiopharmaceutical Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Radiopharmaceutical Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Radiopharmaceutical Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Radiopharmaceutical Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Radiopharmaceutical Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL RADIOPHARMACEUTICAL REVENUE BY REGION
7.1 Global Radiopharmaceutical Revenue by Region
7.1.1 Global Radiopharmaceutical Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Radiopharmaceutical Revenue by Region (2019-2024)
7.1.3 Global Radiopharmaceutical Revenue by Region (2025-2030)
7.1.4 Global Radiopharmaceutical Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Radiopharmaceutical Revenue (2019-2030)
7.2.2 North America Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Radiopharmaceutical Revenue (2019-2030)
7.3.2 Europe Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Radiopharmaceutical Revenue (2019-2030)
7.4.2 Asia-Pacific Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Radiopharmaceutical Revenue (2019-2030)
7.5.2 LAMEA Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Bracco Imaging
8.1.1 Bracco Imaging Comapny Information
8.1.2 Bracco Imaging Business Overview
8.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
8.1.5 Bracco Imaging Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Bayer Radiopharmaceutical Product Portfolio
8.2.5 Bayer Recent Developments
8.3 Mallinckrodt
8.3.1 Mallinckrodt Comapny Information
8.3.2 Mallinckrodt Business Overview
8.3.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
8.3.5 Mallinckrodt Recent Developments
8.4 Nordion
8.4.1 Nordion Comapny Information
8.4.2 Nordion Business Overview
8.4.3 Nordion Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Nordion Radiopharmaceutical Product Portfolio
8.4.5 Nordion Recent Developments
8.5 Triad Isotopes
8.5.1 Triad Isotopes Comapny Information
8.5.2 Triad Isotopes Business Overview
8.5.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
8.5.5 Triad Isotopes Recent Developments
8.6 Lantheus
8.6.1 Lantheus Comapny Information
8.6.2 Lantheus Business Overview
8.6.3 Lantheus Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Lantheus Radiopharmaceutical Product Portfolio
8.6.5 Lantheus Recent Developments
8.7 IBA Group
8.7.1 IBA Group Comapny Information
8.7.2 IBA Group Business Overview
8.7.3 IBA Group Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 IBA Group Radiopharmaceutical Product Portfolio
8.7.5 IBA Group Recent Developments
8.8 GE Healthcare
8.8.1 GE Healthcare Comapny Information
8.8.2 GE Healthcare Business Overview
8.8.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
8.8.5 GE Healthcare Recent Developments
8.9 China Isotope & Radiation
8.9.1 China Isotope & Radiation Comapny Information
8.9.2 China Isotope & Radiation Business Overview
8.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
8.9.5 China Isotope & Radiation Recent Developments
8.10 Jubilant Pharma
8.10.1 Jubilant Pharma Comapny Information
8.10.2 Jubilant Pharma Business Overview
8.10.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
8.10.5 Jubilant Pharma Recent Developments
8.11 Eli Lilly
8.11.1 Eli Lilly Comapny Information
8.11.2 Eli Lilly Business Overview
8.11.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
8.11.5 Eli Lilly Recent Developments
8.12 Advanced Accelerator Applications
8.12.1 Advanced Accelerator Applications Comapny Information
8.12.2 Advanced Accelerator Applications Business Overview
8.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
8.12.5 Advanced Accelerator Applications Recent Developments
8.13 SIEMENS
8.13.1 SIEMENS Comapny Information
8.13.2 SIEMENS Business Overview
8.13.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 SIEMENS Radiopharmaceutical Product Portfolio
8.13.5 SIEMENS Recent Developments
8.14 Dongcheng
8.14.1 Dongcheng Comapny Information
8.14.2 Dongcheng Business Overview
8.14.3 Dongcheng Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Dongcheng Radiopharmaceutical Product Portfolio
8.14.5 Dongcheng Recent Developments
8.15 Navidea
8.15.1 Navidea Comapny Information
8.15.2 Navidea Business Overview
8.15.3 Navidea Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Navidea Radiopharmaceutical Product Portfolio
8.15.5 Navidea Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Radiopharmaceutical Value Chain Analysis
9.1.1 Radiopharmaceutical Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Radiopharmaceutical Production Mode & Process
9.2 Radiopharmaceutical Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Radiopharmaceutical Distributors
9.2.3 Radiopharmaceutical Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Radiopharmaceutical Market Size, 2019 VS 2023 VS 2030
1.3 Global Radiopharmaceutical Market Size Estimates and Forecasts (2019-2030)
1.4 Global Radiopharmaceutical Sales Estimates and Forecasts (2019-2030)
1.5 Global Radiopharmaceutical Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL RADIOPHARMACEUTICAL MARKET DYNAMICS
2.1 Radiopharmaceutical Industry Trends
2.2 Radiopharmaceutical Industry Drivers
2.3 Radiopharmaceutical Industry Opportunities and Challenges
2.4 Radiopharmaceutical Industry Restraints
3 RADIOPHARMACEUTICAL MARKET BY MANUFACTURERS
3.1 Global Radiopharmaceutical Revenue by Manufacturers (2019-2024)
3.2 Global Radiopharmaceutical Sales by Manufacturers (2019-2024)
3.3 Global Radiopharmaceutical Average Sales Price by Manufacturers (2019-2024)
3.4 Global Radiopharmaceutical Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Radiopharmaceutical Manufacturers, Product Type & Application
3.7 Global Radiopharmaceutical Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Radiopharmaceutical Market CR5 and HHI
3.8.2 Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2023
3.8.3 2023 Radiopharmaceutical Tier 1, Tier 2, and Tier
4 RADIOPHARMACEUTICAL MARKET BY TYPE
4.1 Radiopharmaceutical Type Introduction
4.1.1 Actinium-225
4.1.2 Lutetium-177
4.1.3 Radium-223
4.1.4 Holmium-166
4.1.5 Other
4.2 Global Radiopharmaceutical Sales by Type
4.2.1 Global Radiopharmaceutical Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Radiopharmaceutical Sales by Type (2019-2030)
4.2.3 Global Radiopharmaceutical Sales Market Share by Type (2019-2030)
4.3 Global Radiopharmaceutical Revenue by Type
4.3.1 Global Radiopharmaceutical Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Radiopharmaceutical Revenue by Type (2019-2030)
4.3.3 Global Radiopharmaceutical Revenue Market Share by Type (2019-2030)
5 RADIOPHARMACEUTICAL MARKET BY APPLICATION
5.1 Radiopharmaceutical Application Introduction
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Other
5.2 Global Radiopharmaceutical Sales by Application
5.2.1 Global Radiopharmaceutical Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Radiopharmaceutical Sales by Application (2019-2030)
5.2.3 Global Radiopharmaceutical Sales Market Share by Application (2019-2030)
5.3 Global Radiopharmaceutical Revenue by Application
5.3.1 Global Radiopharmaceutical Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Radiopharmaceutical Revenue by Application (2019-2030)
5.3.3 Global Radiopharmaceutical Revenue Market Share by Application (2019-2030)
6 GLOBAL RADIOPHARMACEUTICAL SALES BY REGION
6.1 Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Radiopharmaceutical Sales by Region (2019-2030)
6.2.1 Global Radiopharmaceutical Sales by Region (2019-2024)
6.2.2 Global Radiopharmaceutical Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Radiopharmaceutical Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Radiopharmaceutical Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Radiopharmaceutical Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Radiopharmaceutical Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL RADIOPHARMACEUTICAL REVENUE BY REGION
7.1 Global Radiopharmaceutical Revenue by Region
7.1.1 Global Radiopharmaceutical Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Radiopharmaceutical Revenue by Region (2019-2024)
7.1.3 Global Radiopharmaceutical Revenue by Region (2025-2030)
7.1.4 Global Radiopharmaceutical Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Radiopharmaceutical Revenue (2019-2030)
7.2.2 North America Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Radiopharmaceutical Revenue (2019-2030)
7.3.2 Europe Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Radiopharmaceutical Revenue (2019-2030)
7.4.2 Asia-Pacific Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Radiopharmaceutical Revenue (2019-2030)
7.5.2 LAMEA Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Bracco Imaging
8.1.1 Bracco Imaging Comapny Information
8.1.2 Bracco Imaging Business Overview
8.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
8.1.5 Bracco Imaging Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Bayer Radiopharmaceutical Product Portfolio
8.2.5 Bayer Recent Developments
8.3 Mallinckrodt
8.3.1 Mallinckrodt Comapny Information
8.3.2 Mallinckrodt Business Overview
8.3.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
8.3.5 Mallinckrodt Recent Developments
8.4 Nordion
8.4.1 Nordion Comapny Information
8.4.2 Nordion Business Overview
8.4.3 Nordion Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Nordion Radiopharmaceutical Product Portfolio
8.4.5 Nordion Recent Developments
8.5 Triad Isotopes
8.5.1 Triad Isotopes Comapny Information
8.5.2 Triad Isotopes Business Overview
8.5.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
8.5.5 Triad Isotopes Recent Developments
8.6 Lantheus
8.6.1 Lantheus Comapny Information
8.6.2 Lantheus Business Overview
8.6.3 Lantheus Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Lantheus Radiopharmaceutical Product Portfolio
8.6.5 Lantheus Recent Developments
8.7 IBA Group
8.7.1 IBA Group Comapny Information
8.7.2 IBA Group Business Overview
8.7.3 IBA Group Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 IBA Group Radiopharmaceutical Product Portfolio
8.7.5 IBA Group Recent Developments
8.8 GE Healthcare
8.8.1 GE Healthcare Comapny Information
8.8.2 GE Healthcare Business Overview
8.8.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
8.8.5 GE Healthcare Recent Developments
8.9 China Isotope & Radiation
8.9.1 China Isotope & Radiation Comapny Information
8.9.2 China Isotope & Radiation Business Overview
8.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
8.9.5 China Isotope & Radiation Recent Developments
8.10 Jubilant Pharma
8.10.1 Jubilant Pharma Comapny Information
8.10.2 Jubilant Pharma Business Overview
8.10.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
8.10.5 Jubilant Pharma Recent Developments
8.11 Eli Lilly
8.11.1 Eli Lilly Comapny Information
8.11.2 Eli Lilly Business Overview
8.11.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
8.11.5 Eli Lilly Recent Developments
8.12 Advanced Accelerator Applications
8.12.1 Advanced Accelerator Applications Comapny Information
8.12.2 Advanced Accelerator Applications Business Overview
8.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
8.12.5 Advanced Accelerator Applications Recent Developments
8.13 SIEMENS
8.13.1 SIEMENS Comapny Information
8.13.2 SIEMENS Business Overview
8.13.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 SIEMENS Radiopharmaceutical Product Portfolio
8.13.5 SIEMENS Recent Developments
8.14 Dongcheng
8.14.1 Dongcheng Comapny Information
8.14.2 Dongcheng Business Overview
8.14.3 Dongcheng Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Dongcheng Radiopharmaceutical Product Portfolio
8.14.5 Dongcheng Recent Developments
8.15 Navidea
8.15.1 Navidea Comapny Information
8.15.2 Navidea Business Overview
8.15.3 Navidea Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Navidea Radiopharmaceutical Product Portfolio
8.15.5 Navidea Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Radiopharmaceutical Value Chain Analysis
9.1.1 Radiopharmaceutical Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Radiopharmaceutical Production Mode & Process
9.2 Radiopharmaceutical Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Radiopharmaceutical Distributors
9.2.3 Radiopharmaceutical Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Radiopharmaceutical Industry Trends
Table 2. Radiopharmaceutical Industry Drivers
Table 3. Radiopharmaceutical Industry Opportunities and Challenges
Table 4. Radiopharmaceutical Industry Restraints
Table 5. Global Radiopharmaceutical Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Radiopharmaceutical Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Radiopharmaceutical Sales Market Share by Manufacturers
Table 9. Global Radiopharmaceutical Average Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 10. Global Radiopharmaceutical Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Radiopharmaceutical Manufacturers, Product Type & Application
Table 13. Global Radiopharmaceutical Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Radiopharmaceutical by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Actinium-225
Table 17. Major Manufacturers of Lutetium-177
Table 18. Major Manufacturers of Radium-223
Table 19. Major Manufacturers of Holmium-166
Table 20. Major Manufacturers of Other
Table 21. Global Radiopharmaceutical Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 22. Global Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 23. Global Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 24. Global Radiopharmaceutical Sales Market Share by Type (2019-2024)
Table 25. Global Radiopharmaceutical Sales Market Share by Type (2025-2030)
Table 26. Global Radiopharmaceutical Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 27. Global Radiopharmaceutical Revenue by Type (2019-2024) & (M Doses)
Table 28. Global Radiopharmaceutical Revenue by Type (2025-2030) & (M Doses)
Table 29. Global Radiopharmaceutical Revenue Market Share by Type (2019-2024)
Table 30. Global Radiopharmaceutical Revenue Market Share by Type (2025-2030)
Table 31. Major Manufacturers of Oncology
Table 32. Major Manufacturers of Cardiology
Table 33. Major Manufacturers of Other
Table 34. Global Radiopharmaceutical Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 35. Global Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 36. Global Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 37. Global Radiopharmaceutical Sales Market Share by Application (2019-2024)
Table 38. Global Radiopharmaceutical Sales Market Share by Application (2025-2030)
Table 39. Global Radiopharmaceutical Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 40. Global Radiopharmaceutical Revenue by Application (2019-2024) & (M Doses)
Table 41. Global Radiopharmaceutical Revenue by Application (2025-2030) & (M Doses)
Table 42. Global Radiopharmaceutical Revenue Market Share by Application (2019-2024)
Table 43. Global Radiopharmaceutical Revenue Market Share by Application (2025-2030)
Table 44. Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 45. Global Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 46. Global Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 47. Global Radiopharmaceutical Sales Forecasted by Region (2025-2030) & (M Doses)
Table 48. Global Radiopharmaceutical Sales Forecasted Market Share by Region (2025-2030)
Table 49. North America Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 50. North America Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 51. North America Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 52. Europe Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 53. Europe Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 54. Europe Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 55. Asia Pacific Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 56. Asia Pacific Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 57. Asia Pacific Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 58. LAMEA Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 59. LAMEA Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 60. LAMEA Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 61. Global Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 62. Global Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)
Table 63. Global Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)
Table 64. Global Radiopharmaceutical Revenue Market Share by Region (2019-2024)
Table 65. Global Radiopharmaceutical Revenue Market Share by Region (2025-2030)
Table 66. Bracco Imaging Company Information
Table 67. Bracco Imaging Business Overview
Table 68. Bracco Imaging Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. Bracco Imaging Radiopharmaceutical Product Portfolio
Table 70. Bracco Imaging Recent Development
Table 71. Bayer Company Information
Table 72. Bayer Business Overview
Table 73. Bayer Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 74. Bayer Radiopharmaceutical Product Portfolio
Table 75. Bayer Recent Development
Table 76. Mallinckrodt Company Information
Table 77. Mallinckrodt Business Overview
Table 78. Mallinckrodt Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 79. Mallinckrodt Radiopharmaceutical Product Portfolio
Table 80. Mallinckrodt Recent Development
Table 81. Nordion Company Information
Table 82. Nordion Business Overview
Table 83. Nordion Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 84. Nordion Radiopharmaceutical Product Portfolio
Table 85. Nordion Recent Development
Table 86. Triad Isotopes Company Information
Table 87. Triad Isotopes Business Overview
Table 88. Triad Isotopes Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 89. Triad Isotopes Radiopharmaceutical Product Portfolio
Table 90. Triad Isotopes Recent Development
Table 91. Lantheus Company Information
Table 92. Lantheus Business Overview
Table 93. Lantheus Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 94. Lantheus Radiopharmaceutical Product Portfolio
Table 95. Lantheus Recent Development
Table 96. IBA Group Company Information
Table 97. IBA Group Business Overview
Table 98. IBA Group Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 99. IBA Group Radiopharmaceutical Product Portfolio
Table 100. IBA Group Recent Development
Table 101. GE Healthcare Company Information
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 104. GE Healthcare Radiopharmaceutical Product Portfolio
Table 105. GE Healthcare Recent Development
Table 106. China Isotope & Radiation Company Information
Table 107. China Isotope & Radiation Business Overview
Table 108. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 109. China Isotope & Radiation Radiopharmaceutical Product Portfolio
Table 110. China Isotope & Radiation Recent Development
Table 111. Jubilant Pharma Company Information
Table 112. Jubilant Pharma Business Overview
Table 113. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 114. Jubilant Pharma Radiopharmaceutical Product Portfolio
Table 115. Jubilant Pharma Recent Development
Table 116. Eli Lilly Company Information
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 119. Eli Lilly Radiopharmaceutical Product Portfolio
Table 120. Eli Lilly Recent Development
Table 121. Advanced Accelerator Applications Company Information
Table 122. Advanced Accelerator Applications Business Overview
Table 123. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 124. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
Table 125. Advanced Accelerator Applications Recent Development
Table 126. SIEMENS Company Information
Table 127. SIEMENS Business Overview
Table 128. SIEMENS Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 129. SIEMENS Radiopharmaceutical Product Portfolio
Table 130. SIEMENS Recent Development
Table 131. Dongcheng Company Information
Table 132. Dongcheng Business Overview
Table 133. Dongcheng Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 134. Dongcheng Radiopharmaceutical Product Portfolio
Table 135. Dongcheng Recent Development
Table 136. Navidea Company Information
Table 137. Navidea Business Overview
Table 138. Navidea Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 139. Navidea Radiopharmaceutical Product Portfolio
Table 140. Navidea Recent Development
Table 141. Key Raw Materials
Table 142. Raw Materials Key Suppliers
Table 143. Radiopharmaceutical Distributors List
Table 144. Radiopharmaceutical Customers List
Table 145. Research Programs/Design for This Report
Table 146. Authors List of This Report
Table 147. Secondary Sources
Table 148. Primary Sources
Table 1. Radiopharmaceutical Industry Trends
Table 2. Radiopharmaceutical Industry Drivers
Table 3. Radiopharmaceutical Industry Opportunities and Challenges
Table 4. Radiopharmaceutical Industry Restraints
Table 5. Global Radiopharmaceutical Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Radiopharmaceutical Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Radiopharmaceutical Sales Market Share by Manufacturers
Table 9. Global Radiopharmaceutical Average Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 10. Global Radiopharmaceutical Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Radiopharmaceutical Manufacturers, Product Type & Application
Table 13. Global Radiopharmaceutical Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Radiopharmaceutical by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Actinium-225
Table 17. Major Manufacturers of Lutetium-177
Table 18. Major Manufacturers of Radium-223
Table 19. Major Manufacturers of Holmium-166
Table 20. Major Manufacturers of Other
Table 21. Global Radiopharmaceutical Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 22. Global Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 23. Global Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 24. Global Radiopharmaceutical Sales Market Share by Type (2019-2024)
Table 25. Global Radiopharmaceutical Sales Market Share by Type (2025-2030)
Table 26. Global Radiopharmaceutical Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 27. Global Radiopharmaceutical Revenue by Type (2019-2024) & (M Doses)
Table 28. Global Radiopharmaceutical Revenue by Type (2025-2030) & (M Doses)
Table 29. Global Radiopharmaceutical Revenue Market Share by Type (2019-2024)
Table 30. Global Radiopharmaceutical Revenue Market Share by Type (2025-2030)
Table 31. Major Manufacturers of Oncology
Table 32. Major Manufacturers of Cardiology
Table 33. Major Manufacturers of Other
Table 34. Global Radiopharmaceutical Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 35. Global Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 36. Global Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 37. Global Radiopharmaceutical Sales Market Share by Application (2019-2024)
Table 38. Global Radiopharmaceutical Sales Market Share by Application (2025-2030)
Table 39. Global Radiopharmaceutical Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 40. Global Radiopharmaceutical Revenue by Application (2019-2024) & (M Doses)
Table 41. Global Radiopharmaceutical Revenue by Application (2025-2030) & (M Doses)
Table 42. Global Radiopharmaceutical Revenue Market Share by Application (2019-2024)
Table 43. Global Radiopharmaceutical Revenue Market Share by Application (2025-2030)
Table 44. Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 45. Global Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 46. Global Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 47. Global Radiopharmaceutical Sales Forecasted by Region (2025-2030) & (M Doses)
Table 48. Global Radiopharmaceutical Sales Forecasted Market Share by Region (2025-2030)
Table 49. North America Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 50. North America Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 51. North America Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 52. Europe Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 53. Europe Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 54. Europe Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 55. Asia Pacific Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 56. Asia Pacific Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 57. Asia Pacific Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 58. LAMEA Radiopharmaceutical Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 59. LAMEA Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 60. LAMEA Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 61. Global Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 62. Global Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)
Table 63. Global Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)
Table 64. Global Radiopharmaceutical Revenue Market Share by Region (2019-2024)
Table 65. Global Radiopharmaceutical Revenue Market Share by Region (2025-2030)
Table 66. Bracco Imaging Company Information
Table 67. Bracco Imaging Business Overview
Table 68. Bracco Imaging Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. Bracco Imaging Radiopharmaceutical Product Portfolio
Table 70. Bracco Imaging Recent Development
Table 71. Bayer Company Information
Table 72. Bayer Business Overview
Table 73. Bayer Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 74. Bayer Radiopharmaceutical Product Portfolio
Table 75. Bayer Recent Development
Table 76. Mallinckrodt Company Information
Table 77. Mallinckrodt Business Overview
Table 78. Mallinckrodt Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 79. Mallinckrodt Radiopharmaceutical Product Portfolio
Table 80. Mallinckrodt Recent Development
Table 81. Nordion Company Information
Table 82. Nordion Business Overview
Table 83. Nordion Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 84. Nordion Radiopharmaceutical Product Portfolio
Table 85. Nordion Recent Development
Table 86. Triad Isotopes Company Information
Table 87. Triad Isotopes Business Overview
Table 88. Triad Isotopes Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 89. Triad Isotopes Radiopharmaceutical Product Portfolio
Table 90. Triad Isotopes Recent Development
Table 91. Lantheus Company Information
Table 92. Lantheus Business Overview
Table 93. Lantheus Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 94. Lantheus Radiopharmaceutical Product Portfolio
Table 95. Lantheus Recent Development
Table 96. IBA Group Company Information
Table 97. IBA Group Business Overview
Table 98. IBA Group Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 99. IBA Group Radiopharmaceutical Product Portfolio
Table 100. IBA Group Recent Development
Table 101. GE Healthcare Company Information
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 104. GE Healthcare Radiopharmaceutical Product Portfolio
Table 105. GE Healthcare Recent Development
Table 106. China Isotope & Radiation Company Information
Table 107. China Isotope & Radiation Business Overview
Table 108. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 109. China Isotope & Radiation Radiopharmaceutical Product Portfolio
Table 110. China Isotope & Radiation Recent Development
Table 111. Jubilant Pharma Company Information
Table 112. Jubilant Pharma Business Overview
Table 113. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 114. Jubilant Pharma Radiopharmaceutical Product Portfolio
Table 115. Jubilant Pharma Recent Development
Table 116. Eli Lilly Company Information
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 119. Eli Lilly Radiopharmaceutical Product Portfolio
Table 120. Eli Lilly Recent Development
Table 121. Advanced Accelerator Applications Company Information
Table 122. Advanced Accelerator Applications Business Overview
Table 123. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 124. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
Table 125. Advanced Accelerator Applications Recent Development
Table 126. SIEMENS Company Information
Table 127. SIEMENS Business Overview
Table 128. SIEMENS Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 129. SIEMENS Radiopharmaceutical Product Portfolio
Table 130. SIEMENS Recent Development
Table 131. Dongcheng Company Information
Table 132. Dongcheng Business Overview
Table 133. Dongcheng Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 134. Dongcheng Radiopharmaceutical Product Portfolio
Table 135. Dongcheng Recent Development
Table 136. Navidea Company Information
Table 137. Navidea Business Overview
Table 138. Navidea Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 139. Navidea Radiopharmaceutical Product Portfolio
Table 140. Navidea Recent Development
Table 141. Key Raw Materials
Table 142. Raw Materials Key Suppliers
Table 143. Radiopharmaceutical Distributors List
Table 144. Radiopharmaceutical Customers List
Table 145. Research Programs/Design for This Report
Table 146. Authors List of This Report
Table 147. Secondary Sources
Table 148. Primary Sources
LIST OF FIGURES
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Radiopharmaceutical Market Size (2019-2030) & (US$ Million)
Figure 4. Global Radiopharmaceutical Sales (2019-2030) & (M Doses)
Figure 5. Global Radiopharmaceutical Average Price (USD/Dose) & (2019-2030)
Figure 6. Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Actinium-225 Picture
Figure 9. Lutetium-177 Picture
Figure 10. Radium-223 Picture
Figure 11. Holmium-166 Picture
Figure 12. Other Picture
Figure 13. Global Radiopharmaceutical Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 14. Global Radiopharmaceutical Sales Market Share 2019 VS 2023 VS 2030
Figure 15. Global Radiopharmaceutical Sales Market Share by Type (2019-2030)
Figure 16. Global Radiopharmaceutical Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 17. Global Radiopharmaceutical Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Radiopharmaceutical Revenue Market Share by Type (2019-2030)
Figure 19. Oncology Picture
Figure 20. Cardiology Picture
Figure 21. Other Picture
Figure 22. Global Radiopharmaceutical Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Radiopharmaceutical Sales Market Share 2019 VS 2023 VS 2030
Figure 24. Global Radiopharmaceutical Sales Market Share by Application (2019-2030)
Figure 25. Global Radiopharmaceutical Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 26. Global Radiopharmaceutical Revenue Market Share 2019 VS 2023 VS 2030
Figure 27. Global Radiopharmaceutical Revenue Market Share by Application (2019-2030)
Figure 28. North America Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. North America Radiopharmaceutical Sales Market Share by Country (2019-2030)
Figure 30. U.S. Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 31. Canada Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. Europe Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. Europe Radiopharmaceutical Sales Market Share by Country (2019-2030)
Figure 34. Germany Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. France Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. U.K. Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 37. Italy Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 38. Netherlands Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. Asia Pacific Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. Asia Pacific Radiopharmaceutical Sales Market Share by Country (2019-2030)
Figure 41. China Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. Japan Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. South Korea Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. Southeast Asia Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 45. India Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 46. Australia Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. LAMEA Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. LAMEA Radiopharmaceutical Sales Market Share by Country (2019-2030)
Figure 49. Mexico Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 50. Brazil Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 51. Turkey Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 52. GCC Countries Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 53. Global Radiopharmaceutical Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Global Radiopharmaceutical Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 55. North America Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 56. North America Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. Europe Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 58. Europe Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. Asia-Pacific Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 60. Asia-Pacific Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 61. LAMEA Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 62. LAMEA Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 63. Radiopharmaceutical Value Chain
Figure 64. Manufacturing Cost Structure
Figure 65. Radiopharmaceutical Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Years Considered
Figure 69. Research Process
Figure 70. Key Executives Interviewed
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Radiopharmaceutical Market Size (2019-2030) & (US$ Million)
Figure 4. Global Radiopharmaceutical Sales (2019-2030) & (M Doses)
Figure 5. Global Radiopharmaceutical Average Price (USD/Dose) & (2019-2030)
Figure 6. Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Actinium-225 Picture
Figure 9. Lutetium-177 Picture
Figure 10. Radium-223 Picture
Figure 11. Holmium-166 Picture
Figure 12. Other Picture
Figure 13. Global Radiopharmaceutical Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 14. Global Radiopharmaceutical Sales Market Share 2019 VS 2023 VS 2030
Figure 15. Global Radiopharmaceutical Sales Market Share by Type (2019-2030)
Figure 16. Global Radiopharmaceutical Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 17. Global Radiopharmaceutical Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Radiopharmaceutical Revenue Market Share by Type (2019-2030)
Figure 19. Oncology Picture
Figure 20. Cardiology Picture
Figure 21. Other Picture
Figure 22. Global Radiopharmaceutical Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Radiopharmaceutical Sales Market Share 2019 VS 2023 VS 2030
Figure 24. Global Radiopharmaceutical Sales Market Share by Application (2019-2030)
Figure 25. Global Radiopharmaceutical Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 26. Global Radiopharmaceutical Revenue Market Share 2019 VS 2023 VS 2030
Figure 27. Global Radiopharmaceutical Revenue Market Share by Application (2019-2030)
Figure 28. North America Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. North America Radiopharmaceutical Sales Market Share by Country (2019-2030)
Figure 30. U.S. Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 31. Canada Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. Europe Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. Europe Radiopharmaceutical Sales Market Share by Country (2019-2030)
Figure 34. Germany Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. France Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. U.K. Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 37. Italy Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 38. Netherlands Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. Asia Pacific Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. Asia Pacific Radiopharmaceutical Sales Market Share by Country (2019-2030)
Figure 41. China Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. Japan Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. South Korea Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. Southeast Asia Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 45. India Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 46. Australia Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. LAMEA Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. LAMEA Radiopharmaceutical Sales Market Share by Country (2019-2030)
Figure 49. Mexico Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 50. Brazil Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 51. Turkey Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 52. GCC Countries Radiopharmaceutical Sales and Growth Rate (2019-2030) & (M Doses)
Figure 53. Global Radiopharmaceutical Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Global Radiopharmaceutical Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 55. North America Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 56. North America Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. Europe Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 58. Europe Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. Asia-Pacific Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 60. Asia-Pacific Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 61. LAMEA Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
Figure 62. LAMEA Radiopharmaceutical Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 63. Radiopharmaceutical Value Chain
Figure 64. Manufacturing Cost Structure
Figure 65. Radiopharmaceutical Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Years Considered
Figure 69. Research Process
Figure 70. Key Executives Interviewed
